Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20160306026938N9
IRCT20160306026938N9
Recruiting
Phase 2

Studying the efficacy of a Topical formulation based on Aloe vera, Salix alba and Persea americana on relieving Psoriasis symptoms

Tehran University of Medical Sciences0 sites15 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Tehran University of Medical Sciences
Enrollment
15
Status
Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Patients with mild to moderate psoriasis
  • •Healthy physical condition
  • •Patient's deliberate consent

Exclusion Criteria

  • •Having any systemic disease that affects the skin
  • •Using any topical or oral product to treat psoriasis in the last 4 weeks
  • •Using moisturizers during the study
  • •Any chemicals such as solvents contact during the study without informing the researchers
  • •Patients suffering cancer
  • •Pregnant and lactating women

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Evaluation of the efficacy of a topical formulation containing ASF-1075 in the treatment of chronic hand dermatitis - hand dermatitismale or female patients with chronic hand dermatitis, aged 18 to 70 yearsMedDRA version: 8.1Level: LLTClassification code 10058898Term: Hand dermatitis
EUCTR2005-005793-75-DEAstion Danmark A/S40
Active, not recruiting
Not Applicable
Evaluation of the efficacy of a topical formulation containing ASF-1075 in the treatment of chronic hand dermatitis - hand dermatitis
EUCTR2005-005793-75-DKAstion Danmark A/S40
Recruiting
Phase 1
The evaluation of efficacy of topical formulation of Henna (Lawsonia inermis) in prevention of contact dermatitis in patients using prosthesis
IRCT20171229038126N1Kerman University of Medical Sciences72
Active, not recruiting
Not Applicable
Evaluation of the efficacy of topical formulations containing ASF-1075 in the prevention and treatment of contact dermatitis - contact dermatitis
EUCTR2005-005792-15-DEAstion Danmark A/S20
Not yet recruiting
Phase 3
Evaluation of the effect of formulation Arctium Lappa in the treatment of Mild-to-moderate Acne
IRCT20191111045408N1Mashhad University of Medical Sciences100